Disclosed CapitolDisclosedCapitol
Home
Plans
Chad AI
API
Sign InGet Pro

Never Miss a Trade

Get weekly trade alerts free.

Explore

  • Politician Trades
  • Politicians
  • Executive Branch
  • Companies
  • All Stocks A–Z
  • Leaderboard
  • Compare Politicians
  • Committee Portfolios
  • Chad AI

Money & Policy

  • Government Contracts
  • Lobbying
  • Legislation
  • Campaign Finance
  • Institutional (13F)
  • Whale Watch (13D)

Markets

  • Markets Overview
  • Top Companies
  • Insider Trends
  • Economic Indicators
  • Live News

Resources

  • API Access
  • Developers
  • Data Export
  • Glossary
  • Methodology
  • Data Sources
  • How It Works

Company

  • About Us
  • Press
  • FAQ
  • Pricing
  • vs. Capitol Trades
  • Contact
  • Watchlist

Legal

  • Editorial Standards
  • Corrections
  • Disclaimers
  • Privacy
  • Terms
© 2026 Disclosed Capitol. All rights reserved.
TermsPrivacyDisclaimer
HomeTrades
Chad
WatchlistAccount
All news
EARNINGSEarnings Watch

McCaul, Khanna Active in DAN and COH Ahead of Earnings

Chad
·Saturday, June 27, 2026

Congressional trade filings reveal concentrated activity in stocks preparing to report earnings, led by Dana Incorporated and Cochlear Limited. Representative Michael McCaul recorded four trades in DAN, while Ro Khanna logged three trades in COH. The same lawmakers, along with Gilbert Cisneros, also appear in three TSLA trades according to the latest disclosures. With an aggregate 20 trades linked to a group including Suzan K. DelBene, Scott H. Peters, Greg Steube, and Steve Cohen, the earnings_watch signal shows lawmakers maintaining notable exposure across consumer cyclical, healthcare, and energy names.

Dana Incorporated is scheduled to report Q2 2026 results between July 23 and August 4. Wall Street consensus calls for EPS of $0.66 on revenue near $1.93 billion, reflecting a year-over-year revenue decline of roughly 26 percent. The company delivered mixed Q1 results that included an EPS miss, yet analyst estimates for the current quarter have held relatively steady. Price targets cluster between $30 and $38, with a blend of Buy and Hold ratings. McCaul's activity in this auto-parts supplier comes as the sector navigates softening demand and supply-chain pressures.

Cochlear Limited, the Australian medical device company behind COH, is set to release full-year FY2026 results on August 18. Consensus estimates project EPS of approximately $4.74 on $2.32 billion in revenue. The stock has already absorbed significant downward revisions after an April trading update cited weaker demand, pushing shares to multi-year lows. Despite the pressure, analysts maintain an overall Buy rating with average 12-month targets near A$125. Khanna's trades in both COH and TSLA suggest interest in healthcare innovation alongside consumer cyclical exposure.

Additional filings show activity in AMZN and GOOGL by David J. Taylor and Matthew Robert Van Epps, plus COP and SAR trades tied to McCaul. The absence of clear buy or sell direction in the summary data makes precise positioning difficult to read, yet the cluster of filings immediately before these reports stands out. Similar patterns have drawn investor attention in prior quarters when congressional trades preceded material moves.

The overlap between these politicians and the upcoming earnings calendar does not imply foreknowledge, but the concentration merits monitoring. As consensus forecasts for DAN and COH reflect both challenges and measured optimism, retail investors may watch whether these names deliver upside surprises or further validate recent analyst caution. This is data analysis, not financial advice.

Mentioned in this article

DANCOHTSLAAMZNGOOGLMichael McCaulRo KhannaGilbert Cisneros

This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.